Ad-hoc | 11 April 2005 10:23
aap Implantate AG: Termination of supply agreement for Palacos
Ad hoc announcement §15 WpHG
Termination of supply agreement
aap Implantate AG: Termination of supply agreement for Palacos
Ad hoc announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————
aap Implantate AG: Termination of supply agreement for Palacos
aap has received previous Friday a termination declaration of the long-term
supply agreement of the bone cement Palacos from its supplier Essex Chemie AG,
Switzerland, a subsidiary of Schering Plough, US due to reasons not in
relation to aap.
According to aap’s opinion is the termination invalid and constitutes a breach
of the existing agreement. Therefore aap will, if Essex does actually
discontinue the delivery with Palacos, take legal action and claim for
indemnification.
aap distributes Palacos as a trade product in Germany, but also develops and
produces various bone cements on behalf of international market leaders in
orthopaedics. aap currently analyses alternatives in order to provide a
sufficient supply of bone cement to its customers.
A potential discontinuation of the distribution of Palacos without
introduction of alternative products would result into sales shortfall for
bone cements of approx. EUR 750,000 compared to plan for the remaining
business year 2005. In the business year 2004 aap realized a sales volume of
EUR 2.3 million with this product.
aap confirms the forecasts of a double-digit revenue growth and return to
profitability for the whole year of 2005, released at the financial statements
2004 press conference, March 31st, 2005.
Although revenues from major contracts will be mainly effective in Q3 and Q4
of 2005 (2004 these were mainly realized in Q1) aap has achieved total sales
in Q1 above last years reference period.
aap Implantate AG
Lorenzweg 5
12099 Berlin
Deutschland
ISIN: DE0005066609
WKN: 506660
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart
End of ad hoc announcement (c)DGAP 11.04.2005
111023 Apr 05